Up next
Tags

Lodha launched its Lifesciences Hub at Palava with Encube Ethicals as their first client.

By Varun Singh

Lodha, closed a deal with Encube Ethicals, an integrated pharmaceutical company dedicated to topical products, to develop ~100,000 sq. ft. flagship R&D ‘Centre of Excellence’ at Palava. The project is part of the Lodha Lifesciences Hub, which is spread across 25 acres and is Mumbai’s first systematically developed life sciences cluster.

Expected to complete by 2023, the project will entail the development of Encube Ethicals’ R&D Centre of Excellence. In lines with Lodha’s commitment to fostering growth and contributing towards the larger goal of nation building, this strategic partnership will further provide a host of job opportunities in the city.

This project will be carried out in two phases, with the first phase being delivered by next year. Encube Ethicals plans to have 250 R&D-related jobs in the first building itself.

Despite the presence of majority of Indian life sciences companies’ headquarters in Mumbai, the desired R&D ecosystem has not been developed yet in MMR, given the lack of quality and compliant spaces, and infrastructure. The Lodha Lifesciences Hub at Palava offers next-generation lab spaces. It is built on the core principles of ESG with a host of ecosystem benefits, 100% compliant spaces, and all requisite government approvals in place. It is centrally located with close proximity to the current hubs of Mahape, Taloja, Ambernath, and more than ~1000 R&D employees are already residing in Palava.

Mehul Shah, MD, Encube Ethicals, said, “Lodha Lifesciences Hub at Palava provides a unique value proposition for life sciences R&D centres – high quality development, 100% compliance, streamlined approval process and talent friendly ecosystem. Encube’s partnership with Lodha for its flagship R&D Center of Excellence is expected to spread across ~100,000 sq. ft. Encube’s focus of 24+ years in topicals research will be leveraged to expand its domestic and global product portfolio.”

Shaishav Dharia, CEO, Townships, and Rental Assets, Lodha, said, “With this association, we are elated to achieve the milestone of building Mumbai’s first systematically developed life sciences cluster. Partnerships like these further leverage Lodha’s pledge towards the nation’s economic growth and the development of the country at large. Understanding the specific requirements to set up an advanced R&D hub in a space like MMR, Lodha Lifesciences Hub at Palava with its plethora of benefits serves as a one-stop solution and similar deals like the one with Encube Ethicals will further help fortify pharma-centric developments in the area.”

Along with residential and commercial hubs for the residents, Palava is also evolving into a greater location that now comprises pharma and R&D spaces. Additionally, Palava Industrial and Logistics Parks recently inked a deal with Aptar Pharma, a US based global manufacturer of consumer dispensing packaging and drug delivery devices.

SHARE ON
TwitterWhatsappFacebookBufferLinkedInPin It
You May Also Like
Real estate stocks opened sharply higher as Indian markets rallied, with the Nifty Realty index leading sectoral gains. Broad-based buying across developers signals strong sentiment, but investors remain cautious about interest rate risks and profit booking later in the day.

🏗️ Realty Stocks Open Mildly Positive as Markets Begin Trade; Sector Awaits Clear Intraday Signals

Realty stocks opened slightly positive as large developers anchored early trade while mid-caps remained mixed. The sector is expected to trade range-bound unless strong intraday triggers emerge.
Manju Yagnik

Advantages of buying property during its new launch phase

By Manju Yagnik, Vice Chairperson of Nahar Group and Senior Vice President…
In a major relief for homebuyers, ITAT Mumbai has ruled that stamp duty valuation for tax purposes must be taken from the booking date—even if the allotment letter is unregistered—protecting buyers from unfair tax demands caused by builder delays.

Income Tax Tribunal Mumbai: Booking Date Matters for Stamp Duty Valuation, Even Without Registered Agreement

In a major relief for homebuyers, ITAT Mumbai has ruled that stamp duty valuation for tax purposes must be taken from the booking date—even if the allotment letter is unregistered—protecting buyers from unfair tax demands caused by builder delays.
“In a verdict that will resonate across Maharashtra, the Bombay High Court has held that the lives and safety of housing society members cannot be held hostage to a developer’s commercial interests. After 13 years of complete inaction, the Court refused to block redevelopment, declaring: the right to safe homes must prevail over builder profits.”

Bombay HC: Safe Homes Trump Builder Profits — Society Wins 13-Year Redevelopment Battle

“In a verdict that will resonate across Maharashtra, the Bombay High Court has held that the lives and safety of housing society members cannot be held hostage to a developer’s commercial interests. After 13 years of complete inaction, the Court refused to block redevelopment, declaring: the right to safe homes must prevail over builder profits.”